Dr. Michael Rio, PharmD
Dr. Michael Rio is a licensed pharmacist affiliated with the Behrakis Health Sciences Center at Northeastern University, 360 Huntington Avenue, Boston, MA 02115. He holds a Doctor of Pharmacy (PharmD) degree and reviews the medical content published on Domperidone Motilium Guide for factual accuracy, appropriate safety framing, and clarity.
Dr. Rio's review covers pharmacology and drug-mechanism explanations, dosage and administration information, documented side effects and interactions, and how regulatory and safety warnings are described. His focus is on making sure that what is published reflects current, well-supported information and gives appropriate weight to known risks — not on promoting any particular product, care pathway, or purchasing decision.
How our review process works
Content on this site follows a two-step process. First, an article is drafted with reference to publicly available regulatory and clinical sources, including FDA communications, other national regulators, and peer-reviewed literature where relevant. Second, Dr. Rio reviews the draft specifically for medical accuracy: correct mechanism-of-action descriptions, accurate side-effect and interaction information, and safety warnings that are neither overstated nor understated. Pages are re-reviewed when a meaningful update is made, and the "reviewed" date shown at the top of the underlying page data reflects the most recent check.
What reviewer sign-off does and doesn't mean
A pharmacist's review confirms that the general medical information on a page is accurate and reasonably current at the time of review. It does not mean Dr. Rio has evaluated any individual reader's health situation, and it does not create a pharmacist-patient or doctor-patient relationship. For decisions about your own health, medications, or a family member's care, please consult your own physician or pharmacist directly.
Editorial independence
Domperidone Motilium Guide does not sell, dispense, or ship medication, and Dr. Rio's review role is limited to the accuracy of published information. He is not compensated based on traffic, rankings, or any commercial outcome tied to specific pages.